Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Hematology
•
Rheumatoid Arthritis
How would you manage a patient with RA with newly diagnosed T-LGLL who was previously treated with Enbrel and is now flaring off Enbrel while on low dose methotrexate?
Related Questions
Would you consider caplacizumab in a pregnant patient with iTTP?
When considering a biologic for seropositive RA after failure of methotrexate or triple therapy, do you consider using abatacept as a first line biologic or would prefer choosing TNFi?
When do you recommend initiation of targeted therapies in active RA with history of malignancy?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
What is your approach to screening for malignancy in dermatomyositis patients who do not have a high risk antibody profile and whose disease responds well to treatment?
How do you treat MAS in patients with systemic JIA or AOSD with HLA-DRB1*15 alleles given risk for DRESS hypersensitivity to IL1 or IL6 inhibitor therapy?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
What is your approach to biologic therapy in older adults (80+) with RA and CKD?
Does the pattern on chest CT help determine which patients with RA-ILD will respond to immunosuppression?
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?
